MedTrace Logo

First-void Urine Samples for the Follow-up of Women Treated for High-grade Cervical Intraepithelial Neoplasia (CIN)

NCT03542513 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 65

Last updated 2025-06-13

No results posted yet for this study

Summary

The aim of this study is to analyse biomarkers in first-void urine for improved follow-up of women treated for high grade cervical intraepithelial neoplasia (CIN).

Conditions

Interventions

DEVICE

Colli-Pee

Urine samples will be collected with the Colli-Pee device (Novosanis NV, Wijnegem, Belgium).

DEVICE

Qvintip

Vaginal self-samples will be collected with the Qvintip (Aprovix AB, Uppsala, Sweden).

Sponsors & Collaborators

  • University Hospital, Antwerp

    collaborator OTHER

  • Universiteit Antwerpen

    lead OTHER

Principal Investigators

  • Pierre Van Damme · Centre for the Evaluation of Vaccination

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-30
Primary Completion
2022-12-12
Completion
2024-09-25
FDA Device
Yes

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03542513 on ClinicalTrials.gov